The Global In-Vitro Fertilization Market is estimated to rise from US$529.8 Mn in 2017 to US$725.9 Mn by 2022 end. The market is projected to expand at a CAGR of 6.5% during the forecast period of 2017–2022.The rising number of couples, men or women, suffering with various anatomic factors such as tubal disease and endometriosis, ovulatory disorders, and unexplained cases of infertility in various parts of the world is a key trend stoking the demand for in-vitro fertilization treatments. The prevalence of infertility can be attributed to an amalgamation of factors such as genetic, lifestyle-induced, and unprotected intercourse. The increase in the number of known genetic disorders in developed nations among fertile couples also bodes well for the in-vitro fertilization market. These couples opt for IVF to prevent the transmission of the diseases to their children. The wide availability of genetic tests in numerous advanced nations is anticipated to further boost the detection of these genetic disorders, thereby fueling the demand for IVF procedures. The availability of routine insurance coverage for IVF procedures is gaining traction in several developed and developing countries, which is expected to open up lucrative market avenues. This is also expected to bring down the cost of treatment.
The report segments the global in-vitro fertilization market into North America, Latin America, Middle East and Africa, Europe, Asia Pacific excluding Japan (APEJ), and Japan. Of these, the APEJ in-vitro fertilization market is the most lucrative market expanding at a CAGR of 6.7% during the forecast period to reach US$ 235.9 Mn by 2022 end. The dominance of the region is driven by burgeoning demand for IVF treatments, attributed to the rising infertility in women and men in several countries. Improvements in health care is likely to further bolster the uptake in the region.
In recent years, there have various market forces instrumental for bringing down the cost of IVF treatment, which also points to the consolidation of the business landscape. Leading players operating in the global in-vitro fertilization market include Thermo Fisher Scientific, Inc., Cook Medical, Merck KGaA, Vitrolife AB, Ovascience, Inc., CooperSurgical, EMD Serono, Inc., Genea Ltd., Rocket Medical PLC, and Fertility Focus Ltd.
Report Overview, with TOC -
Comments
Post a Comment